Mapping peptide-protein interactions by amine-reactive cleavable photoaffinity reagents

04 May 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Photoaffinity labeling followed by tandem mass spectrometry is an often used strategy to identify protein targets of small molecule drugs or drug candidates, which -- under ideal conditions -- enables the identification of the actual drug binding site. In case of bioactive peptides, however, identifying the distinct binding site is hampered because of complex fragmentation patterns during tandem mass spectrometry. We here report the development and use of small cleavable photoaffinity reagents that allow functionalization of bioactive peptides for light-induced covalent binding to their protein targets. Upon cleavage of the covalently linked peptide drug, a chemical remnant of a defined mass remains on the bound amino acid which is then used to unambiguously identify the drug binding site. Applying our approach to known peptide-drug/protein pairs with reported crystal structures, such as the calmodulin-mellitin interaction, we were able to validate the identified binding sites based on structural models. Overall, our cleavable photoaffinity labeling strategy represents a powerful tool to enable the identification of protein targets and specific binding sites of a wide variety of bioactive peptides in the future.

Keywords

Bioactive peptides
target identification
cleavable linkers

Supplementary materials

Title
Description
Actions
Title
Supplementary material
Description
Supplemental Schemes, Figures and Tables, Experimental procedures, and copies of chromatograms
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.